Tumor Immunotherapy
Stem Cell Therapy for Tissue Regeneration
Targeted Cancer Therapies
Cancer Therapies
Combination Therapies and Personalized Medicine
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Jul 8, 2025
![Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F62334.jpg&w=3840&q=75)
Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography
Published on: February 17, 2022
1Department of Hematology & Oncology, Nagoya City University Graduate School of Medical Sciences.
Chimeric antigen receptor (CAR)-T cell therapies targeting B-cell maturation antigen (BCMA) show promise for relapsed and refractory multiple myeloma (RR-MM). Further research is needed to overcome resistance and improve long-term outcomes for patients.
Area of Science: